MedTrace Logo

Clinical-biological Score for Upper Gastrointestinal Bleeding

NCT05688501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-01-26

No results posted yet for this study

Summary

Gastrointestinal bleeding is a frequent reason for consultation in the Emergency Department. It is a real emergency associated with fairly significant morbidity and mortality.

The incidence of upper gastrointestinal bleeding (HDH) has been reported to be 67-103 per 100,000 adults per year in the UK with mortality rates of 2%-8%.

While Lower Gastrointestinal Bleeding (LBHB) has a lower incidence estimated at 33 per 100,000 adults per year. Additionally, compared to HDB, HDB appears to have less need for hemostatic intervention and lower mortality.

Conditions

  • Gastro Intestinal Bleeding

Interventions

OTHER

descriptiv group

no intervention

Sponsors & Collaborators

  • Hôpital Universitaire Sahloul

    lead OTHER

Principal Investigators

  • Riadh Boukef, professor · CHU Sahloul, Emergency department, sousse

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2022-09-01
Completion
2022-09-01

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05688501 on ClinicalTrials.gov